1
Back
D

Drug Testing and Analysis

IF2.7
Papers127
Citations
Journal Papers 124
Publication Date
delete
Administration Study of Bedinvetmab, an Antinerve Growth Factor Monoclonal Antibody, in Horses for Doping Control Purposes
deleteDrug Testing and Analysis
IF2.7
delete2026-07-05
delete0
PREAI
deleteHiu Wing Cheung; Kin-Sing Wong; Yung-Ching Choi; Wai Him Kwok; Yat-Ming So; Adrian F. Farrington; Emmie N. M. Ho
deleteShare
deleteSave
Reproducibility of Serum Androgen Concentrations by Liquid Chromatography Mass Spectrometry in Healthy Male and Female Athletes
deleteDrug Testing and Analysis
IF2.7
delete2026-06-30
delete0
deleteOAAI
deleteD. J. Handelsman; S. Bermon
deleteShare
deleteSave
Isolation and Characterization of New Tadalafil Analogues in Male Sexual Herbal Supplements
deleteDrug Testing and Analysis
IF2.7
delete2026-06-25
delete0
PREAI
deleteHakan Göker; Fatima Doganc; Mehmet Gumustas; Emre Saklica
deleteShare
deleteSave
Exploring the Potential of Population-Optimized Red Blood Cell Antigens and Platelet HLA Typing for Homologous Blood Transfusion Detection in Japanese Athletes
deleteDrug Testing and Analysis
IF2.7
delete2026-06-23
delete0
PREAI
deleteAtsushi Momobayashi; Masato Okano
deleteShare
deleteSave
Development of an Enzyme-Linked Immunosorbent Assay for Pegmolesatide in Doping Analysis: An Initial Testing Method
deleteDrug Testing and Analysis
IF2.7
delete2026-06-19
delete0
PREAI
deleteJie Chen; Chengshuai Niu; Xinmiao Zhou
deleteShare
deleteSave
Investigations Into the Metabolism and Elimination of Tesofensine in Human Urine
deleteDrug Testing and Analysis
IF2.7
delete2026-06-19
delete0
deleteOAAI
deleteO. Krug; A. Thomas; M. Thevis
deleteShare
deleteSave
Etomidate Analogues in E-Cigarettes: Linking Structural Characterization to Regional Early Warning
deleteDrug Testing and Analysis
IF2.7
delete2026-06-19
delete0
PREAI
deletePo-Jung Hsueh; Lien-Chung Wei
deleteShare
deleteSave
Chemical Characterization of an Emerging Designer Steroid, 6-Bromo-androst-4-en-3,17-dione, via NMR and LC-HRMS and GC-HRMS
deleteDrug Testing and Analysis
IF2.7
delete2026-06-18
delete0
PREAI
deleteGenye He; Sisi Zhu; Xin Liu; Zhanliang Wang; Lisi Zhang; Jianghai Lu; Jing Li
deleteShare
deleteSave
Identification of Synthetic Urine by Analysis of Stable Carbon and Nitrogen Isotope Ratios and Comparison to Established GC-MS/MS and LC-MS/MS Analysis
deleteDrug Testing and Analysis
IF2.7
delete2026-06-18
delete0
deleteOAAI
deleteHülsemann Frank; Franke Laura; Dirk K. Wissenbach; Fußhöller Gregor; Thevis Mario
deleteShare
deleteSave
Detection of Testosterone Esters in Urine: Evidence of Trace-Level Detectability in Doping Control Samples
deleteDrug Testing and Analysis
IF2.7
delete2026-06-17
delete0
deleteOAAI
deleteDaniel Pecher; Guro Forsdahl; Biljana Stojanovic; Günter Gmeiner
deleteShare
deleteSave
In Vitro Metabolism of Δ8-, Δ9-, and Δ10-THC in Human Hepatocytes: Distinct Δ10-THC Biotransformation and Implications for Drug Testing
deleteDrug Testing and Analysis
IF2.7
delete2026-06-02
delete0
deleteOAAI
deleteRobert Kronstrand; Henrik Green; Markus Loh; Fabian Rüttimann; Manuela Carla Monti
deleteShare
deleteSave
Investigation of the In Vitro and In Vivo Metabolism and μ-Opioid Receptor Affinity of the Nitazene N-Pyrrolidino Fluetonitazene
deleteDrug Testing and Analysis
IF2.7
delete2026-06-02
delete0
deleteOAAI
deleteSeverin Zemp; Gaia Alluisetti; Wolfgang Weinmann; Bettina Schrag; Frank Sporkert; Maurine Leclerc; Katharina Elisabeth Grafinger
deleteShare
deleteSave
Comparing the Stability and Detectability of Testosterone Esters in Capillary Serum, Sodium Fluoride-Containing Plasma, and Dried Blood Spots After Testosterone Ester Administration
deleteDrug Testing and Analysis
IF2.7
delete2026-05-31
delete0
PREAI
deleteJenna M. Goodrum; Vinod S. Nair; Andre K. Crouch; Daniel Eichner; Geoffrey D. Miller
deleteShare
deleteSave
Investigations Into the Metabolism and Elimination of Flmodafinil and Fladrafinil for Sports Drug Testing Purposes
deleteDrug Testing and Analysis
IF2.7
delete2026-05-28
delete0
deleteOAAI
deleteO. Krug; S. Guddat; C. Görgens; K. Walpurgis; F. Toma; A. Thomas; M. Thevis
deleteShare
deleteSave
Exploring Cerumen as an Alternative Matrix for Drug Detection and Quantification: Method Development and Application in Clinical Samples
deleteDrug Testing and Analysis
IF2.7
delete2026-05-26
delete0
deleteOAAI
deleteDimitrios Phaedon Kevrekidis; Helen G. Gika; Georgios Panagiotoglou; Eleni Parlapani; Pavlos Pavlidis; Nikolaos Raikos
deleteShare
deleteSave
The Effect of Permanent Dye Colour on Illicit Drug and Metabolite Levels in Chemically Treated Hair
deleteDrug Testing and Analysis
IF2.7
delete2026-05-25
delete0
PREAI
deleteAmy Duda
deleteShare
deleteSave
Phase I Metabolism of Novel Phencyclidine Derivative 3-Cl-PCP: In Vitro Studies With Pooled Human Liver Microsomes and Investigation of a Post-Mortem Case
deleteDrug Testing and Analysis
IF2.7
delete2026-05-24
delete0
deleteOAAI
deleteJohannes Kutzler; Tobias Veit; Thomas Keller; Volker Auwärter
deleteShare
deleteSave
Analytical Methods for the Quantification of Drugs and Their Metabolites in Human Hair: A Systematic Review From 2010 to 2025
deleteDrug Testing and Analysis
IF2.7
delete2026-05-24
delete0
PREAI
deleteMarine Elluard; Léo Miri; Nicolas Caron; Jean-François Bussières
deleteShare
deleteSave
The Evolution of Precision Anti-Doping From UGT2B17 Polymorphism Insights to Integrated Detection Frameworks
deleteDrug Testing and Analysis
IF2.7
delete2026-05-22
delete0
PREAI
deleteJiahui Cheng; Zhongquan Li; Tingyuan Zheng; Ruiqi Ma; Xiaomeng Xiang; Xiaojun Deng; Bing Liu
deleteShare
deleteSave
Characterization of Novel Metabolites of the HIF Stabilizer JNJ-42041935 in Rats Using LC-HRMS for Doping Control Purposes: A Pilot Study
deleteDrug Testing and Analysis
IF2.7
delete2026-05-21
delete0
PREAI
deleteJinghua Hou; Sheng Yang
deleteShare
deleteSave